Buckhead Capital Management LLC Abiomed Inc Transaction History

Buckhead Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$224.73 - $338.64 $259,563 - $391,129	-1,155 Reduced 37.98%	1,886 $467,000
Q1 2022 May 10, 2022	BUY	$277.25 - $366.29 $28,002 - $36,995	101 Added 3.44%	3,041 $1.01 Million
Q3 2021 Nov 05, 2021	BUY	$310.19 - $376.2 $183,942 - $223,086	593 Added 25.27%	2,940 $957,000
Q2 2021 Aug 06, 2021	BUY	$262.71 - $351.17 $18,915 - $25,284	72 Added 3.16%	2,347 $733,000
Q1 2021 Apr 27, 2021	BUY	$285.92 - $355.13 $191,566 - $237,937	670 Added 41.74%	2,275 $725,000
Q4 2020 Feb 09, 2021	BUY	$251.88 - $324.2 $141,052 - $181,552	560 Added 53.59%	1,605 $520,000
Q2 2020 Aug 03, 2020	BUY	$141.4 - $257.09 $147,763 - $268,659	1,045 New	1,045 $252,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Buckhead Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Buckhead Capital Management LLC with notifications on news.